title: The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation.
authors.forename: L
authors.initials: L
authors.lastname: Jungbauer
authors.forename: C
authors.initials: C
authors.lastname: Dobias
authors.forename: C
authors.initials: C
authors.lastname: Stöllberger
authors.forename: F
authors.initials: F
authors.lastname: Weidinger
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy*; D003430:Cross-Sectional Studies; D004347:Drug Interactions; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D012306:Risk; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D014812:Vitamin K